Skip to main content

Table 1 Summary of the publically available GEO datasets used in the study

From: Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues

Gene expression omnibus Type samples Characteristics\subtype Number of samples (n) Original publications
(Accession number)     
GDS2250/GSE7904 Patients Normal/non-basal-like/basal n = 47 Richardson AL, Wang ZC, De Nicolo A, Lu X et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006 Feb;9(2):121–32.
GDS1329 Patients Apocrine/basal/luminal n = 49 Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 2005 Jul 7;24(29):4660–71.
GSE34211 Cell lines Luminal/basal n = 35 Hook KE, Garza SJ, Lira ME, Ching KA et al. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735. Mol Cancer Ther 2012 Mar;11(3):710-9
GSE12777 Cell lines Luminal/basal n = 49 Hoeflich KP, O’Brien C, Boyd Z, Cavet G et al. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clin Cancer Res 2009 Jul 15; 15(14):4649–64.
  1. The datasets were retrieved from GEO based on search terms. The types of samples used for the particular study, the number of samples processed and the reference for the original publications are listed. The characteristics and subtype designations were assigned by the original investigators.